FROVOCIMAB
UNII 87PZ955YRB

Substance Identification & Data

This profile provides standardized clinical and technical data for Frovocimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 87PZ955YRB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1643672-70-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

87PZ955YRB

CAS Registry Number

1643672-70-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

FROVOCIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175068

National Cancer Institute reference terminology for clinical and research data.

INN ID

10859

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

EF-59

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Frovocimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FROVOCIMAB

Common Names & Synonyms

FROVOCIMAB [INN]

FROVOCIMAB [USAN]

FROVOCIMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G4, ANTI-(PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9(PCSK9))(HUMAN MONOCLONAL LY3015014 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LY3015014 LIGHT-CHAIN, DIMER

SYS

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HUMAN PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (NEURAL APOPTOSIS-REGULATED CONVERTASE 1, PROPROTEIN CONVERTASE 9, SUBTILISIN/KEXIN-LIKE PROTEASE PC9, EC=3.4.21.-))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.4 HEAVY CHAIN (1-451) (HUMANIZED VH (HOMO SAPIENS IGHV3-21*01 (89%) (IGHD)-IGHJ4*01) (8.8.18) (1-125) -HOMO SAPIENS IGHG4*01 (H S10>P(233), CH2 F4>A(239),L5>A(240), CH3 K107>-(DEL)) (126-451)) (139-219')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-219') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV2-28*01 (87%) IGKJ1*01) (11.3.9) (1'-112') -HOMO SAPIENS IGKC*01 (113'-219')), DIMER (231-231'':234-234'')-BISDISULFIDE

SYS